FSD Pharma Inc.
NASDAQ:HUGE
0.09 (USD) • At close August 14, 2024
Overzicht | Financiële gegevens
| Bedrijfsnaam | FSD Pharma Inc. |
| Symbool | HUGE |
| Munteenheid | USD |
| Prijs | 0.09 |
| Beurswaarde | 66,671 |
| Dividendpercentage | 0% |
| 52-weken bereik | 0.087 - 109.193 |
| Industrie | Drug Manufacturers—Specialty & Generic |
| Sector | Healthcare |
| CEO | Mr. Zeeshan Saeed |
| Website | https://www.fsdpharma.com |
An error occurred while fetching data.
Over FSD Pharma Inc.
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)




